The impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays

被引:15
|
作者
de Beukelaar, Janet W.
Gratama, Jan W.
Smitt, Peter A. Sillevis
Verjans, Georges M.
Kraan, Jaco
Luider, Theo M.
Burgers, Peter C.
机构
[1] Erasmus Univ, Med Ctr, Dept Neurol, Lab Neurooncol, NL-3015 GE Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3015 GE Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands
关键词
D O I
10.1002/rcm.2958
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein-spanning peptide pools have proven valuable as a screening tool for detecting T-lymphocyte responses against a wide range of proteins. We have used this approach in our search for T cells reactive to the onconeural protein HuD. We found positive responses in only 3 of 127 individuals; however, these were highly unusual in that the same class I HLA alleles and peptides were involved. These T-cell responses were not confirmed when peptides re-synthesized by the same manufacturer with similar and with higher purity levels were used. Our observations indicated that these T-cell responses were not directed against the designed HuD peptides. Here, we report on W comparisons of the peptide batches analyzed by matrix-assisted laser desorption/ionization Fourier transform mass spectrometry (MALDI-FTMS) that did - and did not - elicit T-cell responses and (ii) a detailed analysis of the various by-products of peptides, irrespective of T-cell assay outcome. We found numerous differences between the peptide batches, such as omissions of amino acids in the primary structure of the peptides. Furthermore, some batches revealed strong interactions with calcium ions or contained sulfated peptides. Our data reveal that different batches from the same peptide may contain artefacts that influence the outcome of HLA-restricted T-cell response assays. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1282 / 1288
页数:7
相关论文
共 50 条
  • [21] MOLECULAR MAPPING OF A HISTOCOMPATIBILITY-RESTRICTED IMMUNODOMINANT T-CELL EPITOPE WITH SYNTHETIC AND NATURAL PEPTIDES - IMPLICATIONS FOR T-CELL ANTIGENIC STRUCTURE
    BERKOWER, I
    BUCKENMEYER, GK
    BERZOFSKY, JA
    JOURNAL OF IMMUNOLOGY, 1986, 136 (07): : 2498 - 2503
  • [22] MODIFICATION OF THE T-CELL RESPONSIVENESS TO SYNTHETIC PEPTIDES BY SUBSTITUTING AMINO-ACIDS ON AGRETOPES
    OGASAWARA, K
    WAMBUA, PP
    GOTOHDA, T
    ONOE, K
    INTERNATIONAL IMMUNOLOGY, 1990, 2 (03) : 219 - 224
  • [23] T-CELL LINES SELECTED WITH SYNTHETIC PEPTIDES ARE HIGHLY ENCEPHALITOGENIC IN SJL/J MICE
    BOURDETTE, DN
    VANDENBARK, AA
    HASHIM, G
    WHITHAM, RH
    OFFNER, H
    JOURNAL OF NEUROIMMUNOLOGY, 1989, 22 (03) : 255 - 260
  • [24] T-CELL RESPONSES TO SYNTHETIC THYROID PEROXIDASE PEPTIDES IN AUTOIMMUNE THYROID-DISEASE
    TANDON, N
    FREEMAN, M
    WEETMAN, AP
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (01): : 56 - 60
  • [25] T-CELL RECOGNITION OF INSULIN PEPTIDES
    NAQUET, P
    ELLIS, J
    DELOVITCH, TL
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 498 - 498
  • [26] T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
    Eoin F. McKinney
    James C. Lee
    David R. W. Jayne
    Paul A. Lyons
    Kenneth G. C. Smith
    Nature, 2015, 523 : 612 - 616
  • [27] T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
    McKinney, Eoin F.
    Lee, James C.
    Jayne, David R. W.
    Lyons, Paul A.
    Smith, Kenneth G. C.
    NATURE, 2015, 523 (7562) : 612 - +
  • [28] T-CELL RECOGNITION OF A TUMOR-ASSOCIATED GLYCOPROTEIN AND ITS SYNTHETIC CARBOHYDRATE EPITOPES - STIMULATION OF ANTICANCER T-CELL IMMUNITY INVIVO
    HENNINGSSON, CM
    SELVARAJ, S
    MACLEAN, GD
    SURESH, MR
    NOUJAIM, AA
    LONGENECKER, BM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 25 (03) : 231 - 241
  • [29] T-cell metabolic profiling with bioluminescent assays
    Bach, Maggie
    Karassina, Natasha
    Gilden, Julia
    Leippe, Donna
    Valley, Mike
    Sylvester, Kayla
    Vidugiriene, Jolanta
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
    Dourthe, Marie Emilie
    Courtois, Lucien
    Andrieu, Guillaume P.
    Simonin, Mathieu
    Touzart, Aurore
    Lhermitte, Ludovic
    Petit, Arnaud
    Boissel, Nicolas
    Baruchel, Andre
    Asnafi, Vahid
    Macintyre, Elizabeth
    HEMASPHERE, 2023, 7 (04):